IP Library Granted Patent US 10,286,100
Granted Patent B2
US 10,286,100 · App. 15/514,670 · Granted May 14, 2019

Medical dressings comprising fluid management articles and methods of using same

Inventors: Jennifer N. Hanson (Saint Paul, MN); Ibrahim A. El-Hedok (Woodbury, MN); Hassan Sahouani (Hastings, MN); Bradley W. Eaton (Woodbury, MN)
Assignee: 3M INNOVATIVE PROPERTIES COMPANY
A61L15/26A61L15/16A61L15/44C08L33/08C08L71/02C09D133/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,286,100
App. No.
15/514,670
Granted
May 14, 2019
Kind
B2
Abstract

Medical dressings and methods of using same. The medical dressing can include a fluid management article. The fluid management article can include a fibrous substrate and porous polymeric particles. At least 50% of the porous polymeric particles are bound to the fibrous substrate. Methods of using the medical dressings can include applying the medical dressing to the target site, such that the fluid management article is in fluid communication with the target site.

Claims (37)

1. A medical dressing comprising:

a fluid management article comprising:

1) a fibrous substrate; and

2) porous polymeric particles, wherein at least 50% of the porous polymeric particles are bound to the fibrous substrate, wherein the porous polymeric particles comprise a polymerized product of a first monomer of Formula (I)

wherein p is an integer equal to at least 1 and R 1 is hydrogen or alkyl,

wherein the product is formed in a reaction mixture comprising:

a) a first phase having a first volume and comprising

i) a compound of Formula (II)

wherein n is an integer equal to at least 1, and

ii) a nonionic surfactant; and

b) a second phase having a second volume and being dispersed in the first phase, wherein the first volume is greater than the second volume and wherein the second phase comprises;

i) a monomer composition comprising at least 10 weight percent of the first monomer based on a total weight of the monomer composition, and

ii) a poly(propylene glycol) having a weight average molecular weight of at least 500 grams/mole, wherein the poly(propylene glycol) used as a porogen does not form a portion of the polymerized product.

2. The medical dressing of claim 1 , further comprising a backing configured to cover at least a portion of the fluid management article.

3. The medical dressing of claim 2 , wherein the backing includes a compression dressing.

4. The medical dressing of claim 2 , wherein the backing includes a first major surface and a second major surface opposite the first major surface, the second major surface comprising a backing adhesive, the backing adhesive being coupled to the first major surface of the fluid management article.

5. The medical dressing of claim 1 , wherein the fluid management article includes a first major surface and a second major surface opposite the first major surface, the second major surface comprising a skin-contact adhesive.

6. The medical dressing of claim 5 , wherein the skin-contact adhesive is pattern coated on the second major surface of the fluid management article.

7. The medical dressing of claim 5 , wherein the skin-contact adhesive is provided by at least a portion of the fibrous substrate.

8. The medical dressing of claim 5 , further comprising a backing configured to cover at least a portion of the fluid management article.

9. The medical dressing of claim 8 , wherein the backing includes a first major surface and a second major surface opposite the first major surface, the second major surface comprising a backing adhesive, the backing adhesive being coupled to the first major surface of the fluid management article.

10. The medical dressing of claim 9 , wherein the backing adhesive comprises an acrylate-based adhesive, and the skin-contact adhesive comprises an acidic adhesive.

11. The medical dressing of claim 1 , wherein the fluid management article comprises a particle loading of at least about 10% based on total dry weight of the article.

12. The medical dressing of claim 1 , wherein the monomer composition further comprises a second monomer of Formula (III) or Formula (IV)

wherein

R 1 is hydrogen or methyl;

Y is a single bond, alkylene, oxyalkylene, or poly(oxyalkylene);

R 2 is a carbocyclic group or heterocyclic group; and

R 3 is a linear or branched alkyl.

13. The medical dressing of claim 1 , wherein the monomer composition further comprises a second monomer that is a hydroxyl-containing monomer of Formula (V) or Formula (VI),

wherein

R 1 is hydrogen or methyl;

R 4 is an alkyl substituted with one or more hydroxyl groups or is a group of formula —(CH 2 CH 2 O) q CH 2 CH 2 OH where q is an integer equal to at least 1; and

R 5 is an alkylene substituted with at least one hydroxyl group and the group Ar is an aryl group.

14. The medical dressing of claim 1 , wherein an active agent comprising an antimicrobial agent or moisture is adsorbed within at least some of the pores of the porous polymeric particles.

15. The medical dressing of claim 1 wherein at least some of the porous polymeric particles are bound to the fibrous substrate with an adhesive, a binder, or a combination thereof.

16. A method of moving fluid away from a target site, the method comprising applying the medical dressing of claim 1 to the target site, such that the fluid management article is in fluid communication with the target site.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2017
From: HANSON, JENNIFER N.; EL-HEDOK, IBRAHIM A.; SAHOUANI, HASSAN; EATON, BRADLEY W.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 041752/0392 →
Continuity (2)
Provisional Application 62058386 · Oct 1, 2014
Related Publication 20170216476A1 · Aug 3, 2017